If a company is profitable, generates earnings and has more assets than liabilities, it can legally enforce a buyback. Let me be clear: I’m not saying that it will happen. Instead, I’m simply reiterating the fact that the company would have the option to under these implied circumstances. Many OTC companies claim that they can perform a buyback, despite not being eligible to begin with, therefore it would be a very significant condition for DCAC to be in.